Literature DB >> 10216068

Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

S Faderl1, M Talpaz, H M Kantarjian, Z Estrov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10216068

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

2.  The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.

Authors:  B Maes; V Vanhentenrijk; I Wlodarska; J Cools; B Peeters; P Marynen; C de Wolf-Peeters
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.

Authors:  You Kyoung Lee; Dong Wha Lee; Yoo Li Kim; Seok Lee; Chang Ki Min; Yoo-Jin Kim; Il-Hoan Oh; Tai-Gyu Kim; Chun Choo Kim; Dong-Wook Kim
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.

Authors:  T Miyamoto; I L Weissman; K Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Correlation between BCR-ABL expression and tumor burden is restricted to the transition from minor to major cytogenetic response in interferon treated CML patients.

Authors:  László Kereskai; János A Vass; Mária Kneif; László Pajor
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

Review 6.  Biologic and clinical aspects of autologous stem cell transplantation with mobilized peripheral blood cells in chronic myelogenous leukemia.

Authors:  F Frassoni
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

7.  Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Authors:  K Beiske; S A Burchill; I Y Cheung; E Hiyama; R C Seeger; S L Cohn; A D J Pearson; K K Matthay
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

Review 8.  Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review.

Authors:  E V Morozova; Y Y Vlasova; M V Pryanishnikova; K V Lepik; B V Afanasyev
Journal:  Biomark Insights       Date:  2015-12-08

9.  Coexistence of p210BCR-ABL and CBFβ-MYH11 fusion genes in myeloid leukemia: A report of 4 cases.

Authors:  Yuan-Yuan Wang; Wen-Jing Ding; Feng Jiang; Zi-Xing Chen; Jian-Nong Cen; Xiao-Fei Qi; Jian-Ying Liang; Dan-Dan Liu; Jin-Lan Pan; Su-Ning Chen
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.